High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: Comparison to C3H and C57 mice

Cancer Letters

Volumn 246, Issue 1-2, 2007, Pages 115-121

  Iwai, Shuji ^a   Murai, Takashi ^b   Makino, Susumu ^b   Min, Wei ^a   Morimura, Keiichirou ^a   Mori, Satoru ^a   Hagihara, Atsushi ^a   Seki, Shuichi ^a   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

diethylnitrosamine; DNA oxidative stress; fatty liver; hepatocarcinogenesis

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DIETHYLNITROSAMINE; DNA; DRINKING WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C3H MOUSE; C57BL MOUSE; CANCER MODEL; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; FATTY LIVER; IMMUNOHISTOCHEMISTRY; INBRED STRAIN; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ALKYLATING AGENTS; ANIMALS; DEOXYGUANOSINE; DIETHYLNITROSAMINE; DISEASE PROGRESSION; DNA; FATTY LIVER; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED STRAINS; PROLIFERATING CELL NUCLEAR ANTIGEN; SPECIES SPECIFICITY;

EID: 33845655596     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.02.008     Document Type: Article

References (24)

1. Soga M., Kishimoto Y., Kawaguchi J., Nakai Y., Kawamura Y., Inagaki S., et al. The FLS mouse: a new inbred strain with spontaneous fatty liver. Lab. Anim. Sci. 49 3 (1999) 269-275
2. Soga M., Kishimoto Y., Kawamura Y., Inagaki S., Makino S., and Saibara T. Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver. Cancer Lett. 196 1 (2003) 43-48
3. Diwan B.A., Rice J.M., Ohshima M., and Ward J.M. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice. Carcinogenesis 7 2 (1986) 215-220
4. Lee G.H., Nomura K., and Kitagawa T. Comparative study of diethylnitrosamine-initiated two-stage hepatocarcinogenesis in C3H, C57BL and BALB mice promoted by various hepatopromoters. Carcinogenesis 10 12 (1989) 2227-2230
5. Drinkwater N.R., and Ginsler J.J. Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis 7 10 (1986) 1701-1707
6. Drinkwater N.R., and Bennett L.M. Genetic control of carcinogenesis in experimental animals. Prog. Exp. Tumor Res. 33 (1991) 1-20
7. Floyd R.A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11 9 (1990) 1447-1450
8. Halliwell B., and Aruoma O.I. DNA damage by oxygen-derived species, its mechanism and measurement in mammalian systems. Fed Eur Biochem Soc Lett. 281 1-2 (1991) 9-19
9. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res. 387 3 (1997) 147-163
10. Nakae D., Kobayashi Y., Akai H., Andoh N., Satoh H., Ohashi K., et al. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res. 57 7 (1997) 1281-1287
11. Iwai S., Karim R., Kitano M., Sukata T., Min W., Morimura K., et al. Role of oxidative DNA damage caused by carbon tetrachloride-induced liver injury-enhancement of MeIQ-induced glutathione S-transferase placental form-positive foci in rats. Cancer Lett. 179 1 (2002) 15-24
12. Nakae D., Mizumoto Y., Kobayashi E., Noguchi O., and Konishi Y. Improved genomic/nuclear DNA extraction for 8-hydroxydeoxyguanosine analysis of small amounts of rat liver tissue. Cancer Lett. 97 2 (1995) 233-239
13. Kasai H., Nishimura S., Kurokawa Y., and Hayashi Y. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis 8 12 (1987) 1959-1961
14. Robertson G., Leclercq I., and Farrell G.C. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol. 281 5 (2001) G1135-G1139
15. Seki S., Kitada T., Yamada T., Sakaguchi H., Nakatani K., and Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J. Hepatol. 37 1 (2002) 56-62
16. Videla L.A., Rodrigo R., Orellana M., Fernandez V., Tapia G., Quinones L., et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. (Lond) 106 3 (2004) 261-268
17. Zen Y., Katayanagi K., Tsuneyama K., Harada K., Araki I., and Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol. Int. 51 2 (2001) 127-131
18. Shimada M., Hashimoto E., Taniai M., Hasegawa K., Okuda H., Hayashi N., et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J. Hepatol. 37 1 (2002) 154-160
19. Hui J.M., Kench J.G., Chitturi S., Sud A., Farrell G.C., Byth K., et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38 2 (2003) 420-427
20. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4 9 (1998) 1065-1067
21. Moriya K., Nakagawa K., Santa T., Shintani Y., Fujie H., Miyoshi H., et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcino-genesis. Cancer Res. 61 11 (2001) 4365-4370
22. Evans R. The effect of azathioprine on host cell infiltration and growth of a murine fibrosarcoma. Int. J. Cancer 20 1 (1977) 120-128
23. Edel G., and Grundmann E. Selection of liver-colonizing tumor cells from a murine fibrosarcoma induced by methylcholanthrene. J. Cancer Res. Clin. Oncol. 108 3 (1984) 274-280
24. Goldsworthy T.L., and Fransson-Steen R. Quantitation of the cancer process in C57BL/6J, B6C3F1 and C3H/HeJ mice. Toxicol. Pathol. 30 1 (2002) 97-105